Mark Ratain to Demography
This is a "connection" page, showing publications Mark Ratain has written about Demography.
Connection Strength
0.019
-
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial. Invest New Drugs. 2011 Jun; 29(3):481-8.
Score: 0.019